US FDA Sets Generic Approval Record, But Generic Sponsors Aren't Celebrating
Executive Summary
FDA relates new record to its plan to increase access to affordable drugs, but Association for Accessible Medicines says approvals alone will not increase competition.
You may also be interested in...
Drug Pricing Activity At US FDA May Be Unique To Gottlieb Tenure
Steven Grossman argues that the former commissioner possessed the credentials to be out front on the pricing issue, unlike other recent FDA commissioners and the current holder of the office.
December ANDA Rush Is Largest In Two Years
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
December ANDA Rush Is Largest Monthly Haul In Two Years
However, the month may be losing its influence over the US FDA's annual submission total.